United-Guardian, Inc.
UGUnited-Guardian, Inc. (UG) is a diversified manufacturer of specialty personal care, health, and industrial products. Founded in 1946, the company develops and markets a range of proprietary formulations, including personal care products, pharmaceuticals, and industrial chemicals, serving clients worldwide. Known for its innovation and quality, United-Guardian focuses on niche markets with unique product offerings.
Dividend History
Investors can expect a dividend payout of $0.30 per share, scheduled to be distributed in 17 days on August 4, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 4, 2026 | $0.30 | 2026-07-28 | 2026-07-28 |
| February 17, 2026 | $0.25 | 2026-02-09 | 2026-02-09 |
| August 1, 2025 | $0.25 | 2025-07-25 | 2025-07-25 |
| February 18, 2025 | $0.35 | 2025-02-10 | 2025-02-10 |
| July 31, 2024 | $0.35 | 2024-07-23 | 2024-07-23 |
Dividends Summary
- Consistent Payer: United-Guardian, Inc. has rewarded shareholders with 48 dividend payments over the past 22 years.
- Total Returned Value: Investors who held UG shares during this period received a total of $17.54 per share in dividend income.
- Latest Payout: The most recent dividend of $0.30/share was paid 151 days ago, on February 17, 2026.
- Dividend Growth: Since 2004, the dividend payout has grown by 100.0%, from $0.15 to $0.30.
Company News
Heather Fisher won an annual stock-picking contest with a 287% average return on three picks, primarily due to an 849% gain in Aehr Test Systems. However, Fisher sold most of her AEHR shares before the dramatic climb, missing out on significant gains. The contest had 42 participants, with 18 beating the S&P 500's 23.3% return.
United-Guardian, Inc. reported Q1 2026 sales increased 15.8% to $2.87M and net income rose 45.9% to $0.18 per share, driven by 24% pharmaceutical sales growth (led by Renacidin) and 21% cosmetic ingredient sales growth. The company also recognized $303K in settlement income from a contract manufacturer. Management expects continued growth in 2026...
United-Guardian, Inc. (NASDAQ:UG) reported a 13% decline in net sales to $10.5M in 2025 from $12.2M in 2024, with net income falling to $2.1M ($0.46 per share) from $3.3M ($0.71 per share). The decline was driven by excess inventory at distributor Ashland Specialty Ingredients, decreased global demand particularly in China due to competition and ...
United-Guardian reported a 16.3% revenue decline in Q2 2025, primarily due to weak cosmetic ingredient sales from distributor inventory issues. Medical lubricants and pharmaceutical products showed growth, with management hopeful for cosmetic sales recovery in the second half of the year.
United-Guardian, Inc. reported a 12% increase in net sales and a 26% increase in net income for fiscal year 2024 compared to 2023. The company saw strong growth in cosmetic ingredients and medical lubricants, but a supply disruption impacted pharmaceutical sales.
